Evidence map›Paper›PMID 27490793›Full record

ArticleClinical & experimental ophthalmology2017

Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation.

Qi N Cui, Yen C Hsia, Shan C Lin, Robert L Stamper, Jennifer Rose-Nussbaumer, Nitisha Mehta, Travis C Porco, Ayman Naseri, Ying Han

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Clinical & experimental ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06680245 (Effect of Mitomycin-C on the Outcomes of Patients Receiving Ahmed Glaucoma Valve Implantation Surgery), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06680245 phase3not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Mitomycin-C on the Outcomes of Patients Receiving Ahmed Glaucoma Valve Implantation Surgery

TypeinterventionalSponsorSt. Joseph's Healthcare HamiltonRan2024 to 2026Enrolled144ConditionsGlaucomaArmsMitomycin c
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Factors associated with vision loss in Black or Hispanic patients 1 year after standalone or combined Ahmed glaucoma valve surgery.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Use of Anti-VEGF Agents in Glaucoma Surgery.Journal of ophthalmology · 2017
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Qi N CuiDepartment of Ophthalmology, University of California, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-5338-0401
Yen C HsiaDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Shan C LinDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Robert L StamperDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Jennifer Rose-NussbaumerDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Nitisha MehtaDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Travis C PorcoDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Ayman NaseriDepartment of Ophthalmology, University of California, San Francisco, California, USA.
Ying HanDepartment of Ophthalmology, University of California, San Francisco, California, USA.
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAMBA, DEEPAK ASHOK · 1985 to 2024
$16.8M
Predictions of Response to Treatment in Fungal KeratitisK23EY025025 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSE-NUSSBAUMER, JENNIFER · 2015 to 2019
$1.2M
NEI NIH HHS P30 EY002162
6 · The paper itself

Abstract

backgroundTo examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation.

designRetrospective consecutive case series.

participantsFifty patients who received Ahmed glaucoma valve implantation from 1999 to 2013 in the San Francisco Veterans Administration Hospital.

methodsThe +INJECTION group received intraoperative mitomycin c followed by postoperative mitomycin c and/or 5-flurouracil, whereas the -INJECTION group did not.

main outcome measuresPrimary outcome was treatment success at 1 year post-implantation. Intraocular pressure, hypertensive phase, and the number of glaucoma medications were also examined.

resultsTwenty-six patients/eyes in the +INJECTION group and 24 patients/eyes in the -INJECTION group were included. Treatment success was higher in the +INJECTION compared with the -INJECTION group (86 vs. 58%; P = 0.04). Intraocular pressure was lower in the +INJECTION compared with the -INJECTION group at 1, 3, 6 and 12 months (P ≪ 0.00001, P = 0.00003, 0.0008 and 0.024). Hypertensive phase occurred less often in the +INJECTION compared with the -INJECTION group (3.8 vs. 54%; P = 0.021). The +INJECTION group required fewer medications compared with the -INJECTION group (P = 0.02, 0.002, 0.003 and 0.008 at 1, 3, 6 and 12 months). Complication rates were comparable between groups (46.2 and 54.2%; P = 0.63).

conclusionsAdjuvant treatment with antifibrotics following Ahmed glaucoma valve implantation decreased the hypertensive phase and improved surgical outcomes without impacting complication rates at 1 year. This study postulates a role for antifibrotics in the postoperative management of Ahmed glaucoma valves.

Indexed as

Glaucoma Drainage ImplantsAdministration, TopicalAgedAntibiotics, AntineoplasticDose-Response Relationship, DrugDrug Therapy, CombinationFluorouracilFollow-Up StudiesGlaucomaHumansImmunosuppressive AgentsInjectionsIntraocular PressureIntraoperative PeriodMaleMitomycinAntibiotics, AntineoplasticFluorouracilImmunosuppressive AgentsMitomycinglaucomaglaucoma drainage implantsintraocular pressuretreatment outcomewound healing

Identifiers

PMID27490793
PMCPMC13012590
OpenAlexW2480682250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.